Bone marrow transplantation for lymphoma is more effective and can assist in achieving deep disease remission and prolonged survival. Lymphoma is a relatively rare but highly curable malignant tumor, and a malignant tumor that can be cured with chemotherapy, divided into Hodgkin’s lymphoma and non-Hodgkin’s lymphoma. 1. ABVD regimen (i.e., doxorubicin, bleomycin, vinblastine, dacarbazine) is used clinically to treat Hodgkin’s lymphoma in four combinations, and regimens such as R-CHOP (rituximab, cyclophosphamide, vinblastine, adriamycin, prednisone) are often used to treat non-Hodgkin’s lymphoma. 2. Lymphoma can be treated by bone marrow transplantation with good efficacy. This includes autologous hematopoietic stem cell transplantation and allogeneic hematopoietic stem cell transplantation, although this regimen is often used for patients who relapse after remission with conventional chemotherapy, and for patients who are chemotherapy-resistant or cannot tolerate chemotherapy. Lymphoma is recommended to be treated in a standardized manner under the guidance of a specialist, and all of the above medications should be used under the guidance of a physician to avoid self-medication.